ROTH STEVEN R
Known title: Sr VP & CFOCIK: 0001132849
Associated companies
Transaction History
| ONTO | ▲ Buy | Grant | 2,667 | $0 | 2/10/2022 | View on chart |
| ONTO | ▼ Sell | Tax Withholding | 778 | $72K | 2/8/2022 | View on chart |
| ONTO | ▲ Buy | Option Exercise | 6,372 | $0 | 2/7/2022 | View on chart |
| ONTO | ▼ Sell | Tax Withholding | 2,374 | $215K | 2/7/2022 | View on chart |
| ONTO | ▼ Sell | Tax Withholding | 792 | $72K | 2/7/2022 | View on chart |
| ONTO | ▼ Sell | Tax Withholding | 855 | $77K | 2/6/2022 | View on chart |
| ONTO | ▼ Sell | Open Market | 5,000 | $525K | 1/14/2022 | View on chart |
| ONTO | ▼ Sell | Open Market | 5,000 | $415K | 11/3/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
RBC initiates Onto Innovation coverage with Outperform rating
RBC Capital has begun tracking Onto Innovation with an Outperform rating and a $400 price target, citing strong spending in wafer fabrication equipment. This move follows a broader wave of positive analyst actions, including upgrades and rising fair value estimates from other firms. The stock is currently trading near its 52-week high, reflecting the renewed institutional interest in the company.
RBC initiates Onto Innovation coverage with Outperform rating. RBC Capital has begun tracking Onto Innovation with an Outperform rating and a $400 price target, citing strong spending in wafer fabrication equipment. This move follows a broader wave of positive analyst actions, including upgrades and rising fair value estimates from other firms. The stock is currently trading near its 52-week high, reflecting the renewed institutional interest in the company.